Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Horizon Aircraft Announces Exercise of Warrants, Providing an Additional $2.7 Million in Gross Proceeds
-
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
-
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Notice of annual general meeting of Gabriel Holding A/S
-
Copenhagen Infrastructure Partners charges to the top of the UK battery stack
-
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology
-
BitMEX Launches Multi Asset Margining: Simplifying Trading for Derivatives Markets
-
Mancini Duffy Acquires Design Styles Architecture (DSA), Expanding the National Design Firm's Footprint in the Southeast Region
-
Billy Horschel Signs with Fury Athletix as Latest Brand Ambassador
-
Immunovia AB (Publ) presents Nomination Committee
-
Holistic care for senior citizen parents of NRIs: Policybazaar and insurer partners join hands for elderly support services
-
Form 8.3 - Warpaint London Plc
-
Novelis Announces Senior Notes Offering
-
Form 8.3 - Renewi Plc
-
Form 8.3 - Learning Technologies Group Plc
-
Alliance Witan PLC - Net Asset Value
-
Icreon Welcomes John Wanek, Former Valtech SVP of Growth
-
Oracle Textura Surpasses $1 Trillion in Construction Payments Processed
-
Fortune Minerals Provides an Update of NICO Project Test Work, Rio Tinto Process Collaboration & Feasibility Study
-
Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
-
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
-
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Pri
-
Ivanhoe Mines Provides 2024 Production Results, 2025 Production Guidance
-
New NPG Forum Paper Calls for Sustainable Solutions for Populations Living in Climate-Sensitive Regions
-
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Abzena Strengthens Board with Appointment of Biopharma Industry Leader, Dr Moncef Slaoui
-
Tower's Big, 250-m Step-Out in Hole 56 at Thunder North Pays Off with a Long, 15.8 m Intersection Averaging 5.80 g/t Gold, Building on Hole 55's 31.5 m of 4.15 g/t Au at Blue Sky
-
Tenet's Business Hub Onboards Some 400 SMEs in a Single Day to Make First Macroeconomic Indexes Viable
-
Andean Precious Metals Receives Final Approval for Uplisting to Toronto Stock Exchange
-
Caprock Engages BBA E&C for an Updated Mineral Resource Estimate on Its Destiny Gold Project
-
Amplify ETFs to Liquidate the Amplify U.S. Alternative Harvest ETF (MJUS)
-
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
-
Nayax, the Leader in Seamless Payment and Commerce Solutions, Set to Unveil 'Retail Your Way' at NRF 2025
-
GoGold Reports 36% Increase in Production at Parral to 551,337 Silver Equivalent Ounces and Provides Outlook for 2025
-
FLOWERS FOODS, INC. TO ACQUIRE SIMPLE MILLS
-
Angitia Biopharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
W. P. Carey Announces 2024 Investment Volume of $1.6 Billion
-
AWP Safety, Backed by Kohlberg & Co., Announces Strategic Acquisitions of Site Barricades, Integrity Traffic and WS Barricade
-
Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
-
A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefining What's Possible in Gene Therapy with Help from Weill Cornell Medicine
-
Red Rover Health Raises $4 Million in Funding to Grow Healthcare App Store Platform
-
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
-
Albertsons Companies, Inc. Reports Third Quarter Fiscal 2024 Results
-
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FOURTH QUARTER AND FULL YEAR 2024 RESULTS AND CONFERENCE CALL
-
Top-Performing Team The Burgman Group Joins Real
-
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
-
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
-
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
-
Gaxos to Participate in The Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico
